InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

TELA Bio, Inc.

TELA Clue Score60
United States Fiscal year ends December CIK 0001561921
$1.11 +5.71% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.11 −91.30% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 8 Nov 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue4.2Operating income−16.9Net income−21.3Fiscal year 2018Revenue8.3 +94.9%Operating income−17.8Net income−21.1Fiscal year 2019Revenue15.4 +86.7%Operating income−19.2Net income−22.4EPS, diluted−17.10Fiscal year 2020Revenue18.2 +17.9%Operating income−25.3Net income−28.8EPS, diluted−2.23Fiscal year 2021Revenue29.5 +61.8%Operating income−29.5Net income−33.3EPS, diluted−2.30Fiscal year 2022Revenue41.4 +40.6%Operating income−39.0Net income−44.3EPS, diluted−2.72Fiscal year 2023Revenue58.5 +41.1%Operating income−44.1Net income−46.7EPS, diluted−2.04Fiscal year 2024Revenue69.3 +18.6%Operating income−34.1Net income−37.8EPS, diluted−1.33Fiscal year 2025Revenue80.3 +15.8%Operating income−33.8Net income−38.8EPS, diluted−0.83
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 4.2 8.3 15.4 18.2 29.5 41.4 58.5 69.3 80.3
Growth +94.9% +86.7% +17.9% +61.8% +40.6% +41.1% +18.6% +15.8%
Operating income −16.9 −17.8 −19.2 −25.3 −29.5 −39.0 −44.1 −34.1 −33.8
Net income −21.3 −21.1 −22.4 −28.8 −33.3 −44.3 −46.7 −37.8 −38.8
Growth
EPS, diluted n/a n/a −17.10 −2.23 −2.30 −2.72 −2.04 −1.33 −0.83

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Gross margin59.6%Operating margin−398.7%Net margin−502.6%Free cash flow margin−388.3%Fiscal year 2018Gross margin35.6%Operating margin−214.9%Net margin−254.9%Free cash flow margin−241.6%Fiscal year 2019Gross margin60.0%Operating margin−124.1%Net margin−145.2%Free cash flow margin−166.5%Fiscal year 2020Gross margin61.7%Operating margin−138.8%Net margin−158.1%Free cash flow margin−135.2%Fiscal year 2021Gross margin63.9%Operating margin−100.0%Net margin−112.9%Free cash flow margin−105.4%Fiscal year 2022Gross margin65.3%Operating margin−94.2%Net margin−106.9%Free cash flow margin−100.5%Fiscal year 2023Gross margin68.6%Operating margin−75.4%Net margin−79.8%Free cash flow margin−70.9%Fiscal year 2024Gross margin67.1%Operating margin−49.2%Net margin−54.6%Free cash flow margin−61.4%Fiscal year 2025Gross margin67.7%Operating margin−42.0%Net margin−48.4%Free cash flow margin−35.7%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 59.6% 35.6% 60.0% 61.7% 63.9% 65.3% 68.6% 67.1% 67.7%
Operating margin −398.7% −214.9% −124.1% −138.8% −100.0% −94.2% −75.4% −49.2% −42.0%
Net margin −502.6% −254.9% −145.2% −158.1% −112.9% −106.9% −79.8% −54.6% −48.4%
Free cash flow margin −388.3% −241.6% −166.5% −135.2% −105.4% −100.5% −70.9% −61.4% −35.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−16.4Capital expenditure−0.1Free cash flow−16.5Fiscal year 2018Operating cash flow−19.9Capital expenditure−0.1Free cash flow−20.0Fiscal year 2019Operating cash flow−25.5Capital expenditure−0.2Free cash flow−25.7Fiscal year 2020Operating cash flow−24.5Capital expenditure−0.2Free cash flow−24.6Fiscal year 2021Operating cash flow−30.4Capital expenditure−0.6Free cash flow−31.1Fiscal year 2022Operating cash flow−40.7Capital expenditure−0.9Free cash flow−41.6Fiscal year 2023Operating cash flow−40.9Capital expenditure−0.6Free cash flow−41.5Fiscal year 2024Operating cash flow−41.6Capital expenditure−1.0Free cash flow−42.6Fiscal year 2025Operating cash flow−28.2Capital expenditure−0.4Free cash flow−28.7
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −16.4 −19.9 −25.5 −24.5 −30.4 −40.7 −40.9 −41.6 −28.2
Capital expenditure −0.1 −0.1 −0.2 −0.2 −0.6 −0.9 −0.6 −1.0 −0.4
Free cash flow −16.5 −20.0 −25.7 −24.6 −31.1 −41.6 −41.5 −42.6 −28.7
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash11.3Shareholders’ equity−108.2Fiscal year 2018Cash17.3Shareholders’ equity−137.9Fiscal year 2019Cash45.3Total debt30.2Net cash (debt)15.1Shareholders’ equity31.0Debt to equity0.98Fiscal year 2020Cash74.4Total debt30.8Net cash (debt)43.6Shareholders’ equity49.0Debt to equity0.63Fiscal year 2021Cash43.9Total debt31.5Net cash (debt)12.4Shareholders’ equity20.1Debt to equity1.57Fiscal year 2022Cash42.0Total debt39.9Net cash (debt)2.1Shareholders’ equity14.3Debt to equity2.79Fiscal year 2023Cash46.7Total debt40.5Net cash (debt)6.2Shareholders’ equity18.9Debt to equity2.15Fiscal year 2024Cash52.7Total debt41.1Net cash (debt)11.5Shareholders’ equity28.5Debt to equity1.45Fiscal year 2025Cash50.8Total debt55.7Net cash (debt)−4.8Shareholders’ equity6.3Debt to equity8.82
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 11.3 17.3 45.3 74.4 43.9 42.0 46.7 52.7 50.8
Total debt n/a n/a 30.2 30.8 31.5 39.9 40.5 41.1 55.7
Net cash (debt) n/a n/a 15.1 43.6 12.4 2.1 6.2 11.5 −4.8
Shareholders’ equity −108.2 −137.9 31.0 49.0 20.1 14.3 18.9 28.5 6.3
Debt to equity n/a n/a 0.98 0.63 1.57 2.79 2.15 1.45 8.82

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
4.2 8.3 15.4 18.2 29.5 41.4 58.5 69.3 80.3
Growth +94.9% +86.7% +17.9% +61.8% +40.6% +41.1% +18.6% +15.8%
2.5 2.9 9.3 11.2 18.8 27.0 40.1 46.5 54.3
Growth +16.2% +215.2% +21.2% +67.5% +43.8% +48.3% +15.9% +16.9%
5.8 4.3 4.2 4.3 6.7 8.9 9.6 8.8 9.2
5.0 4.9 6.2 10.1 12.5 13.9 14.9 14.7 15.7
−16.9 −17.8 −19.2 −25.3 −29.5 −39.0 −44.1 −34.1 −33.8
Growth
n/a n/a n/a n/a n/a −44.3 −46.7 −38.0 −38.6
n/a n/a n/a n/a n/a n/a n/a −0.1 0.2
−21.3 −21.1 −22.4 −28.8 −33.3 −44.3 −46.7 −37.8 −38.8
Growth
Per share
n/a n/a −17.10 −2.23 −2.30 −2.72 −2.04 −1.33 −0.83
n/a n/a −17.10 −2.23 −2.30 −2.72 −2.04 −1.33 −0.83
Growth
n/a n/a 1.8 12.9 14.5 16.3 22.9 28.5 46.9
n/a n/a 1.8 12.9 14.5 16.3 22.9 28.5 46.9
Growth +632.2% +11.9% +12.4% +40.6% +24.7% +64.6%

† The diluted share count jumps at 2020 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 34.5% a year over five years.
  • Operating margin is up 96.7 points on five years ago, at -42.0%.
  • A net loss in 9 of 9 years on file.